Ascendis Pharma A/S Total Liabilities
Ascendis Pharma A/S (ASND) had Total Liabilities of EUR 1.47 billion as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:Liabilities · last filed 2026-02-11
- 2025-12-31: Liabilities 1.47B EUR.
- 2025-09-30: Liabilities 1.33B EUR.
- 2025-06-30: Liabilities 1.28B EUR.
- 2025-03-31: Liabilities 1.25B EUR.
| Period end | Liabilities |
|---|---|
| 2025-12-31 | 1.47B EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 1.33B EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 1.28B EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 1.25B EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 1.29B EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 1.19B EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 1.08B EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 1.04B EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 971.28M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 946.65M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 758.98M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 799.07M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 826.39M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 826.39M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 821.87M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 718.99M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 704.43M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 201.29M EUR 20-F · filed 2023-02-16 |
| 2021-09-30 | 211.67M EUR 6-K · filed 2021-11-10 |
| 2021-06-30 | 164.36M EUR 6-K · filed 2021-08-27 |
| 2021-03-31 | 162.49M EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 141.08M EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 94.54M EUR 6-K · filed 2020-11-12 |
| 2020-06-30 | 83.46M EUR 6-K · filed 2020-08-27 |
| 2020-03-31 | 72.58M EUR 6-K · filed 2020-05-19 |
| 2019-12-31 | 79.62M EUR 20-F · filed 2021-03-10 |
| 2019-09-30 | 74.03M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 92.08M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 45.28M EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 38.92M EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 31.03M EUR 6-K · filed 2018-11-28 |
| 2018-06-30 | 36.64M EUR 6-K · filed 2018-08-29 |
| 2018-03-31 | 17.41M EUR 6-K · filed 2018-05-30 |
| 2017-12-31 | 23.77M EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | 13.46M EUR 20-F · filed 2018-03-28 |